GlassScriptPhysician profile
John T Woeste
NPI 1881684454
$6,082.13
in general payments reported to CMS, 2019-2025
50 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $1,138 · 2021: $1,493 · 2022: $1,099 · 2023: $137 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $660.65 | 2019-2022 | |
| Amgen INC. | $488.43 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $433.85 | 2019-2022 | |
| Abbvie INC. | $354.16 | 2021-2022 | |
| Abbott Laboratories | $342.80 | 2019-2025 | Eterna |
| Flowonix Medical Incorporated | $273.84 | 2019-2020 | |
| Indivior INC. | $273.40 | 2019-2022 | |
| Lilly USA, LLC | $244.08 | 2019-2022 | |
| Allergan, INC. | $227.88 | 2019-2020 | |
| Boston Scientific Corporation | $205.00 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Tersera Therapeutics LLC | $204.09 | 2019-2022 | |
| Almatica Pharma LLC | $202.43 | 2021-2023 | Gralise |
| Becton, Dickinson and Company | $176.38 | 2025 | |
| Biodelivery Sciences International, INC. | $171.09 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $166.47 | 2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Woeste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.